Skip to main content

Advertisement

Table 1 Characteristics of the patients*

From: Salvage thoracic surgery in patients with lung cancer: potential indications and benefits

  Total (n = 30) Group 1 (n = 22) Group 2 (n = 3) Group 3 (n = 5)
Age (years, ± SD) 63 ± 7 63 ± 8 64 ± 3 62 ± 8
Male/Female 26/4 21/1 3/0 2/3
Presence of comorbidity (n, %) 18 (60%) 11 (50%) 2 (67%) 5 (100%)
Operation type (n)     
 Lobectomy 14 11 0 3
 Greater resection 11a 8b 2c 1d
 Segmentectomy 5 3 1 1
Extended resection (n, %)** 16 (53%) 13 (59%) 1 (33%) 2 (40%)
Length of hospital stay (mean days ± SD) 11 ± 4 10 ± 4 14 ± 2 13 ± 9
Mortality (n, %) 1 (3%) 0 0 1 (20%)
Morbidity (n, %) 21 (70%) 14 (64%) 3 (100%) 4 (80%)
Overall survival (mean months ± SD) 19 ± 13 22 ± 13 13 ± 5 6 ± 2
Relapse-free survival (mean months ± SD) 14 ± 12 16 ± 13 9 ± 4 6 ± 2
  1. aPneumonectomy, 8; bilobectomy, 2; lobectomy + segmentectomy, 1
  2. bPneumonectomy, 6; bilobectomy, 1 lobectomy +segmentectomy, 1
  3. cPneumonectomy, 1; bilobectomy, 1
  4. dPneumonectomy, 1
  5. SD: Standart Deviation
  6. *P > 0.05 for all parameters
  7. **Including sleeve resection (bronchial or arterial), chest wall resection, pericardial resection and reconstruction, right atrial resection, and diaphragmatic resection and reconstruction